Patents by Inventor Joachim Hütter
Joachim Hütter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9085572Abstract: The present application relates to novel dipyridyl-dihydropyrazolones, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing.Type: GrantFiled: August 24, 2012Date of Patent: July 21, 2015Assignee: Bayer Intellectual Property GmbHInventors: Ingo Flamme, Jens-Kerim Ergüden, Felix Oehme, Kai Thede, Gunter Karig, Alexander Kuhl, Hanno Wild, Joachim Schuhmacher, Peter Kolkhof, Lars Bärfacker, Joachim Hütter
-
Patent number: 8691850Abstract: The present application relates to novel phenylaminothiazole derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of hypertension and other cardiovascular disorders.Type: GrantFiled: August 30, 2005Date of Patent: April 8, 2014Assignee: Bayer Intellectual Property GmbHInventors: Jens-Kerim Ergüden, Gunter Karig, Ulrich Rosentreter, Barbara Albrecht, Kerstin Henninger, Joachim Hütter, Nicole Diedrichs, Peter Nell, Sabine Arndt, Walter Hübsch, Andreas Knorr, Karl-Heinz Schlemmer, Dirk Brohm
-
Publication number: 20120322772Abstract: The present application relates to novel dipyridyl-dihydropyrazolones, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing.Type: ApplicationFiled: August 24, 2012Publication date: December 20, 2012Applicant: Bayer Intellectual Property GmbHInventors: Ingo FLAMME, Jens-Kerim ERGÜDEN, Felix OEHME, Kai THEDE, Gunter KARIG, Alexander KUHL, Hanno WILD, Joachim SCHUHMACHER, Peter KOLKHOF, Lars BÄRFACKER, Joachim HÜTTER
-
Patent number: 8252817Abstract: The present application relates to novel dipyridyl-dihydropyrazolones, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing.Type: GrantFiled: April 15, 2006Date of Patent: August 28, 2012Assignee: Bayer Intellectual Property GmbHInventors: Ingo Flamme, Jens-Kerim Ergüden, Felix Oehme, Kai Thede, Gunter Karig, Alexander Kuhl, Hanno Wild, Joachim Schuhmacher, Peter Kolkhof, Lars Bärfacker, Joachim Hütter
-
Patent number: 8153160Abstract: The present invention relates to a pharmaceutical dosage form comprising an active ingredient combination of nifedipine and/or nisoldipine and at least one angiotensin II antagonist, characterized in that the active ingredient combination undergoes controlled (modified) release in the body, and to processes for the production thereof, to the use thereof as pharmaceuticals, to the use thereof for the prophylaxis, secondary prophylaxis and/or treatment of disorders, and to the use thereof for manufacturing a pharmaceutical for the prophylaxis, secondary prophylaxis and/or treatment of disorders.Type: GrantFiled: June 29, 2006Date of Patent: April 10, 2012Assignee: Bayer Pharma AktiengesellschaftInventors: Andreas Ohm, Klaus Benke, Hanna Tinel, Joachim Hütter
-
Publication number: 20100144728Abstract: The present invention relates to the use of factor Xa inhibitors, especially of oxazolidinones of the formula (I), for the treatment and/or prophylaxis of pulmonary hypertension, and to the use thereof for the manufacture of medicaments for the treatment and/or prophylaxis of pulmonary hypertension.Type: ApplicationFiled: April 10, 2008Publication date: June 10, 2010Applicant: Bayer Schering Pharma AGInventors: Georges Von Degenfeld, Martina Klein, Elisabeth Perzborn, Joachim Hütter, Gerrit Weimann
-
Publication number: 20100035906Abstract: The present application relates to novel dipyridyl-dihydropyrazolones, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing.Type: ApplicationFiled: April 15, 2006Publication date: February 11, 2010Applicant: BAYER HEALTHCARE AGInventors: Ingo Flamme, Jens-Kerim Ergüden, Felix Oehme, Kai Thede, Gunter Karig, Alexander Kuhl, Hanno Wild, Joachim Schuhmacher, Peter Kolkhof, Lars Bärfacker, Joachim Hütter
-
Publication number: 20100035888Abstract: The present invention relates to pharmaceutical compositions for treating, preventing or managing pulmonary hypertension comprising 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide optionally combined with at least one additional therapeutic agent.Type: ApplicationFiled: October 30, 2006Publication date: February 11, 2010Applicant: Bater Healthcare AGInventors: Peter Sandner, Hanna Tinel, Joachim Hütter, Bernd Riedl, Martina Klein
-
Publication number: 20090214664Abstract: The present invention relates to a pharmaceutical dosage form comprising an active ingredient combination of nifedipine and/or nisoldipine and at least one angiotensin II antagonist, characterized in that the active ingredient combination undergoes controlled (modified) release in the body, and to processes for the production thereof, to the use thereof as pharmaceuticals, to the use thereof for the prophylaxis, secondary prophylaxis and/or treatment of disorders, and to the use thereof for manufacturing a pharmaceutical for the prophylaxis, secondary prophylaxis and/or treatment of disorders.Type: ApplicationFiled: June 29, 2006Publication date: August 27, 2009Applicant: BAYER HEALTHCARE AGInventors: Andreas Ohm, Klaus Benke, Hanna Tinel, Joachim Hütter
-
Publication number: 20090186896Abstract: The invention provides pharmacological compositions comprising PDE-5 and PDE-4 inhibitors, alone or in combination, for the treatment of urological disorders comprising Benign Prostate Hyperplasia (BPH), Lower Urinary Tract Symptoms (LUTS) and in particular irritative symptoms caused by BPH-induced bladder outlet obstruction (BOO). The invention also provides methods of screening for such PDE-5 and PDE-4 inhibitors for use, alone and in combination, in the preparation of medicaments for the treatment of said urological disorders.Type: ApplicationFiled: September 16, 2006Publication date: July 23, 2009Applicant: Bayer HealthCare AGInventors: Ernst Ulbrich, Peter Sandner, Hanna Tinel, Joachim Hütter
-
Publication number: 20090176791Abstract: The present invention relates to pharmaceutical compositions for treating, preventing or managing pulmonary hypertension comprising at least a diaryl urea compound optionally combined with at least one additional therapeutic agent. Useful combinations include e.g. BAY 43-9006 as a diaryl urea compound.Type: ApplicationFiled: October 30, 2006Publication date: July 9, 2009Applicant: BAYER HEALTHCARE AGInventors: Peter Sandner, Hanna Tinel, Joachim Hütter, Bernd Riedl, Martina Klein
-
Patent number: 6833364Abstract: The present invention relates to novel substituted pyrazole derivatives of the general formula (I) in which the substituents R1, R2, R3, A, X and Y are each as defined, and to processes for their preparation and to their use as medicaments, in particular as medicaments for the treatment of cardiovascular disorders.Type: GrantFiled: March 26, 2001Date of Patent: December 21, 2004Assignee: Bayer HealthCare AGInventors: Alexander Straub, Achim Feurer, Cristina Alonso-Alija, Elke Stahl, Johannes-Peter Stasch, Elisabeth Perzborn, Joachim Hütter, Klaus Dembowsky
-
Patent number: 6743798Abstract: The present invention relates to novel substituted pyrazole derivatives of the general formula (I) in which R1, R2, R3 and A are each as defined, and to processes for their preparation and to their use as medicaments, in particular as medicaments for the treatment of cardiovascular disorders.Type: GrantFiled: April 11, 2001Date of Patent: June 1, 2004Assignee: Bayer AktiengesellschaftInventors: Alexander Straub, Achim Feurer, Cristina Alonso-Alija, Johannes-Peter Stasch, Elisabeth Perzborn, Joachim Hütter, Klaus Dembowsky, Elke Stahl
-
Patent number: 6649618Abstract: Novel amidoalkyl-uracil derivatives of the formula (I) in which A represents 1-3 ring atoms and X represents optionally substituted (C2-C10)alkylene or (C3-C8)cycloalkylene as defined in claim 1, a process for their preparation, and their use as medicaments for the prophylaxis and/or treatment of disorders are described.Type: GrantFiled: July 16, 2001Date of Patent: November 18, 2003Assignee: Bayer AktiengesellschaftInventors: Michael Härter, Barbara Albrecht, Michael Gerisch, Gabriele Handke, Joachim Hütter, Axel Jensen, Thomas Krahn, Joachim Mittendorf, Felix Oehme, Karl-Heinz Schlemmer, Henning Steinhagen
-
Patent number: 6462068Abstract: The present invention relates to new heterocyclylmethyl-substituted pyrazole derivatives, processes for their preparation and their use as medicaments, in particular as medicaments for treatment of cardiovascular diseases.Type: GrantFiled: August 23, 2000Date of Patent: October 8, 2002Assignee: Bayer AktiengesellschaftInventors: Alexander Straub, Chantal Fürstner, Ulrich Niewöhner, Thomas Jaetsch, Achim Feurer, Raimund Kast, Johannes-Peter Stasch, Elisabeth Perzborn, Joachim Hütter, Klaus Dembowsky, Dieter Arlt
-
Patent number: 6451805Abstract: The present invention relates to new substituted pyrazole derivatives, processes for their preparation and their use as medicaments, in particular as medicaments for the treatment of cardiovascular disorders.Type: GrantFiled: April 23, 1999Date of Patent: September 17, 2002Assignee: Bayer AktiengesellschaftInventors: Alexander Straub, Chantal Fürstner, Thomas Jaetsch, Achim Feurer, Raimund Kast, Johannes-Peter Stasch, Elisabeth Perzborn, Joachim Hütter, Klaus Dembowsky
-
Patent number: 6414009Abstract: The present invention relates to new heterocyclylmethyl-substituted pyrazole derivatives, processes for their preparation and their use as medicaments, in particular as medicaments for treatment of cardiovascular diseases.Type: GrantFiled: August 25, 2000Date of Patent: July 2, 2002Assignee: Bayer AktiengesellschaftInventors: Alexander Straub, Chantal Fürstner, Ulrich Niewöhner, Thomas Jaetsch, Achim Feurer, Raimund Kast, Johannes-Peter Stasch, Elisabeth Perzborn, Joachim Hütter, Klaus Dembowsky, Dieter Arlt
-
Patent number: 6410740Abstract: The present invention relates to new heterocyclylmethyl-substituted pyrazole derivatives, processes for their preparation and their use as medicaments, in particular as medicaments for treatment of cardiovascular diseases.Type: GrantFiled: August 25, 2000Date of Patent: June 25, 2002Assignee: Bayer AktiengesellschaftInventors: Alexander Straub, Chantal Fürstner, Ulrich Niewöhner, Thomas Jaetsch, Achim Feurer, Raimund Kast, Johannes-Peter Stasch, Elisabeth Perzborn, Joachim Hütter, Klaus Dembowsky, Dieter Arlt
-
Patent number: 6387940Abstract: The present invention relates to new heterocyclylmethyl-substituted pyrazole derivatives, processes for their preparation and their use as medicaments, in particular as medicaments for treatment of cardiovascular diseases.Type: GrantFiled: August 23, 2000Date of Patent: May 14, 2002Assignee: Bayer AktiengesellschaftInventors: Alexander Straub, Chantal Fürstner, Ulrich Niewöhner, Thomas Jaetsch, Achim Feurer, Raimund Kast, Johannes-Peter Stasch, Elisabeth Perzborn, Joachim Hütter, Klaus Dembowsky, Dieter Arlt